Beranda › Limfoma Hodgkin
Uji klinis Limfoma Hodgkin yang merekrut di AS
62 studi untuk Limfoma Hodgkin merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX14 studi
- New York City, NY11 studi
- Baldwin Park, CA9 studi
- Boston, MA9 studi
- Miami, FL8 studi
- Memphis, TN7 studi
- Philadelphia, PA6 studi
- Greenburgh, NY5 studi
- Mountain View, CA5 studi
- Atlanta, GA5 studi
- Durham, NC4 studi
- Aurora, CO4 studi
- Madison, WI4 studi
- Edison, NJ4 studi
- Queens, NY4 studi
- Milwaukee, WI4 studi
- Washington, DC4 studi
- Denver, CO3 studi
- New Rochelle, NY3 studi
- East Norwalk, CT3 studi
- Staten Island, NY3 studi
- Sacramento, CA3 studi
- Baltimore, MD3 studi
- Orange, CA3 studi
- Cincinnati, OH3 studi
- Seattle, WA3 studi
- Columbus, OH3 studi
- Chicago, IL3 studi
- Los Angeles, CA3 studi
- San Francisco, CA3 studi
- Indianapolis, IN3 studi
- Minneapolis, MN3 studi
Berdasarkan negara bagian
- California15 studi
- Colorado5 studi
- Florida12 studi
- Georgia7 studi
- Illinois4 studi
- Indiana4 studi
- Maryland5 studi
- Massachusetts9 studi
- Minnesota4 studi
- New Jersey5 studi
- New York15 studi
- North Carolina6 studi
- Ohio4 studi
- Pennsylvania7 studi
- Tennessee8 studi
- Texas15 studi
- Washington4 studi
- Wisconsin8 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
Menerima pesertaFase 1
Usia 12 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06176690CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Menerima pesertaFase 1
Usia 12 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT02917083Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
Usia 0 hingga 38 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06131801The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT02682667Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT03418038Tissue Collection for Studies of Lymph Cancer
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01676805Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT03618550Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06398457A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05615636Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Menerima pesertaFase 1
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06137144Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT05272384Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07444632Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06421987Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
Menerima pesertaFase 2
Usia 2 hingga 21 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07551583Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07514819ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07021989CD45BE-HSPC + CART-45 Cells
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07451054Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Menerima pesertaFase 1/2
Usia 12 hingga 80 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT05092451ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06090864Personalized NK Cell Therapy in CBT
Menerima pesertaFase 2
Usia 15 hingga 80 · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT02727803A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07020533A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT06150664Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06580002Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.